224 related articles for article (PubMed ID: 30969220)
1. Second Uterine Curettage and the Number of Chemotherapy Courses in Postmolar Gestational Trophoblastic Neoplasia: A Randomized Controlled Trial.
Hemida R; Vos EL; El-Deek B; Arafa M; Toson E; Burger CW; van Doorn HC
Obstet Gynecol; 2019 May; 133(5):1024-1031. PubMed ID: 30969220
[TBL] [Abstract][Full Text] [Related]
2. Predictive factors of relapse in low-risk gestational trophoblastic neoplasia patients successfully treated with methotrexate alone.
Couder F; Massardier J; You B; Abbas F; Hajri T; Lotz JP; Schott AM; Golfier F
Am J Obstet Gynecol; 2016 Jul; 215(1):80.e1-7. PubMed ID: 26829503
[TBL] [Abstract][Full Text] [Related]
3. Curative effect of second curettage for treatment of gestational trophoblastic disease - Results of the Belgian registry for gestational trophoblastic disease.
Vandewal A; Delbecque K; Van Rompuy AS; Noel JC; Marbaix E; Delvenne P; Nisolle M; Van Nieuwenhuysen E; Kridelka F; Vergote I; Goffin F; Han SN
Eur J Obstet Gynecol Reprod Biol; 2021 Feb; 257():95-99. PubMed ID: 33383413
[TBL] [Abstract][Full Text] [Related]
4. Relapse rates after two versus three consolidation courses of methotrexate in the treatment of low-risk gestational trophoblastic neoplasia.
Lybol C; Sweep FC; Harvey R; Mitchell H; Short D; Thomas CM; Ottevanger PB; Savage PM; Massuger LF; Seckl MJ
Gynecol Oncol; 2012 Jun; 125(3):576-9. PubMed ID: 22410329
[TBL] [Abstract][Full Text] [Related]
5. Clinical response to a second uterine curettage in patients with low-risk gestational trophoblastic disease: a pilot study.
Yarandi F; Jafari F; Shojaei H; Izadi-Mood N
J Reprod Med; 2014; 59(11-12):566-70. PubMed ID: 25552129
[TBL] [Abstract][Full Text] [Related]
6. [Therapeutic evaluation of cisplatin, etoposide, and bleomycin chemotherapy regimen in high-risk gestational trophoblastic neoplasia].
Song SQ; Zhang GN
Zhonghua Fu Chan Ke Za Zhi; 2012 Aug; 47(8):571-6. PubMed ID: 23141175
[TBL] [Abstract][Full Text] [Related]
7. Effectiveness and toxicity of first-line methotrexate chemotherapy in low-risk postmolar gestational trophoblastic neoplasia: The New England Trophoblastic Disease Center experience.
Maestá I; Nitecki R; Horowitz NS; Goldstein DP; de Freitas Segalla Moreira M; Elias KM; Berkowitz RS
Gynecol Oncol; 2018 Jan; 148(1):161-167. PubMed ID: 29092742
[TBL] [Abstract][Full Text] [Related]
8. Gestational trophoblastic neoplasia after spontaneous human chorionic gonadotropin normalization following molar pregnancy evacuation.
Braga A; Maestá I; Matos M; Elias KM; Rizzo J; Viggiano MG
Gynecol Oncol; 2015 Nov; 139(2):283-7. PubMed ID: 26383828
[TBL] [Abstract][Full Text] [Related]
9. Second curettage versus conventional chemotherapy in avoiding unnecessary chemotherapy and reducing the number of chemotherapy courses for patients with gestational trophoblastic neoplasia: A systematic review and meta-analysis.
Zhao P; Yu Y; Du M; Xu J; Lu W
Int J Gynaecol Obstet; 2024 Apr; 165(1):34-42. PubMed ID: 37753799
[TBL] [Abstract][Full Text] [Related]
10. The role of repeat uterine evacuation in the management of persistent gestational trophoblastic disease.
Pezeshki M; Hancock BW; Silcocks P; Everard JE; Coleman J; Gillespie AM; Tidy J; Coleman RE
Gynecol Oncol; 2004 Dec; 95(3):423-9. PubMed ID: 15581942
[TBL] [Abstract][Full Text] [Related]
11. Evaluating methotrexate treatment in patients with low-risk postmolar gestational trophoblastic neoplasia.
Growdon WB; Wolfberg AJ; Goldstein DP; Feltmate CM; Chinchilla ME; Lieberman ES; Berkowitz RS
Gynecol Oncol; 2009 Feb; 112(2):353-7. PubMed ID: 19059633
[TBL] [Abstract][Full Text] [Related]
12. Actinomycin D for methotrexate-failed low-risk gestational trophoblastic neoplasia.
Lurain JR; Chapman-Davis E; Hoekstra AV; Schink JC
J Reprod Med; 2012; 57(7-8):283-7. PubMed ID: 22838241
[TBL] [Abstract][Full Text] [Related]
13. Risk factors for second-line dactinomycin failure after methotrexate treatment for low-risk gestational trophoblastic neoplasia: a retrospective study.
Hoeijmakers YM; Sweep F; Lok C; Ottevanger PB
BJOG; 2020 Aug; 127(9):1139-1145. PubMed ID: 32141676
[TBL] [Abstract][Full Text] [Related]
14. Risk adapted single-agent dactinomycin or carboplatin for second-line treatment of methotrexate resistant low-risk gestational trophoblastic neoplasia.
Winter MC; Tidy JA; Hills A; Ireson J; Gillett S; Singh K; Hancock BW; Coleman RE
Gynecol Oncol; 2016 Dec; 143(3):565-570. PubMed ID: 27756557
[TBL] [Abstract][Full Text] [Related]
15. Is chemotherapy necessary for patients with molar pregnancy and human chorionic gonadotropin serum levels raised but falling at 6months after uterine evacuation?
Braga A; Torres B; Burlá M; Maestá I; Sun SY; Lin L; Madi JM; Uberti E; Viggiano M; Elias KM; Berkowitz RS
Gynecol Oncol; 2016 Dec; 143(3):558-564. PubMed ID: 27640962
[TBL] [Abstract][Full Text] [Related]
16. Postmolar choriocarcinoma: An independent risk factor for chemotherapy resistance in low-risk gestational trophoblastic neoplasia.
Strohl AE; Lurain JR
Gynecol Oncol; 2016 May; 141(2):276-280. PubMed ID: 26896825
[TBL] [Abstract][Full Text] [Related]
17. Response: Second curettage versus conventional chemotherapy in avoiding unnecessary chemotherapy and reducing the number of chemotherapy courses for patients with gestational trophoblastic neoplasia: A systematic review and meta-analysis.
Zhao P; Lu W
Int J Gynaecol Obstet; 2024 Jan; 164(1):375-376. PubMed ID: 37924216
[No Abstract] [Full Text] [Related]
18. Efficacy of Oral Vitamin A in Reducing β-hCG Levels in Low-Risk Gestational Trophoblastic Neoplasia Patients.
Hidayat YM; Darmadi A E; Rachmayati S; Kusumah WP; Djuwantono T; Pramatirta AY; Suardi D
Asian Pac J Cancer Prev; 2020 Nov; 21(11):3325-3329. PubMed ID: 33247691
[TBL] [Abstract][Full Text] [Related]
19. The role of hysterotomy in the management of gestational trophoblastic neoplasia.
Tjalma WA; Vermorken JB
Int J Gynecol Cancer; 2006; 16(2):882-3. PubMed ID: 16681777
[TBL] [Abstract][Full Text] [Related]
20. Is chemotherapy always necessary for patients with nonmetastatic gestational trophoblastic neoplasia with histopathological diagnosis of choriocarcinoma?
Braga A; Campos V; Filho JR; Lin LH; Sun SY; de Souza CB; da Silva RCAF; Leal EAS; Silveira E; Maestá I; Madi JM; Uberti EH; Viggiano M; Elias KM; Horowitz N; Berkowitz RS
Gynecol Oncol; 2018 Feb; 148(2):239-246. PubMed ID: 29248195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
